Do no harm. Say no harm. Write no harm.

Pain Manag Nurs

Independent Pain Management Consultant and Educator, Wilmington, North Carolina. Electronic address:

Published: August 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pmn.2022.05.003DOI Listing

Publication Analysis

Top Keywords

harm harm
4
harm write
4
write harm
4
harm
2
write
1

Similar Publications

Objective: Transdermal alcohol concentration (TAC) sensors provide a multidimensional characterization of drinking events that self-reports cannot. These profiles may differ in their associated day-level alcohol-related consequences, but no research has tested this. We address this using multilevel latent profile analysis.

View Article and Find Full Text PDF

This review synthesizes current research on domestic violence and sexual assault, focusing on their short-term and long-term effects on family dynamics, particularly on the development and well-being of children and adolescents. The article employs a curated body of literature, including surveys, reviews, program evaluations, and international health reports, to elucidate the direct and collateral damage caused by such trauma within families. The review critically examines the intersecting consequences of abuse, including immediate psychological distress and long-term socio-economic and educational disruptions for affected youths.

View Article and Find Full Text PDF

Chilaiditi Sign and Syndrome as a Finding in the Emergency Room: A Case Report.

Cureus

December 2024

Clinical Pathology Department, Unidade Local de Saúde do Nordeste, Unidade Hospitalar de Bragança, Bragança, PRT.

The Chilaiditi sign is the presence of a loop of bowel interposed between the liver and the diaphragm. In most cases, the Chilaiditi sign is diagnosed as a rare incidental radiological finding on chest X-rays or the abdomen of asymptomatic patients. When associated with symptoms, it is named Chilaiditi syndrome.

View Article and Find Full Text PDF

Despite significant breakthroughs in frontline cancer research and chemotherapy for hepatocellular carcinoma (HCC), many of the suggested drugs have high toxic side effects and resistance, limiting their clinical utility. Exploring potential therapeutic targets or novel combinations with fewer side effects is therefore crucial in combating this dreadful disease. The current study aims to use a novel combination of ponatinib and gossypol against the HepG2 cell line.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!